Product Information
METHYLPHENIDATE 30 MG/9 HR PATCH is a generic product labeled by Mylan Pharmaceuticals Inc., priced at $7.8904 per EA under NDC 00378826393. Its NADAC has been published 183 times since Feb 22, 2023.
FDA first approved this application on Mar 14, 2022. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
3.3 mg/h
Manufacturer
Mylan Pharmaceuticals Inc.NDC
00378826393
Classification
Generic
Dosage Form
PATCH
Route
TRANSDERMAL
Effective Date
8/19/2026
Active Ingredients
METHYLPHENIDATEApproval Type
Generic (ANDA)
FDA Application
ANDA206497FDA Approved
3/14/2022
TE Code
AB
On Market Since
6/27/2022
Pharmacological Classes
Price Statistics
The NADAC for METHYLPHENIDATE 30 MG/9 HR PATCH has been published 183 times since Feb 22, 2023, and over the history we have for it it has declined 39.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $7.8904 per EA |
|---|---|
| All-time high | $12.9826 (May 10, 2023) |
| All-time low | $7.8904 (Aug 19, 2026) |
| 52-week high | $9.7948 |
| 52-week low | $7.8904 |
| Median price | $9.6178 |
| Average price | $10.4975 |
| Largest weekly change | -9.0% (Jul 17, 2024) |
| Weeks tracked | 183 |
| Tracking since | Feb 22, 2023 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Methylphenidate market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of METHYLPHENIDATE 30 MG/9 HR PATCH?
The current National Average Drug Acquisition Cost (NADAC) for METHYLPHENIDATE 30 MG/9 HR PATCH, manufactured by Mylan Pharmaceuticals Inc., is $7.8904 per EA (NDC 00378826393), effective Aug 19, 2026.
How has the price of METHYLPHENIDATE 30 MG/9 HR PATCH changed over time?
Over the history we have for it, the NADAC for METHYLPHENIDATE 30 MG/9 HR PATCH has declined 39.2%. It has been tracked across 183 weekly CMS publications since Feb 22, 2023.
What are the highest and lowest recorded NADAC prices for METHYLPHENIDATE 30 MG/9 HR PATCH?
Since Feb 22, 2023, the NADAC for METHYLPHENIDATE 30 MG/9 HR PATCH has ranged from a low of $7.8904 (Aug 19, 2026) to a high of $12.9826 (May 10, 2023), with a median of $9.6178 per EA.
Are there cheaper alternatives to METHYLPHENIDATE 30 MG/9 HR PATCH?
No other NADAC-published product currently shares the active ingredient and strength of METHYLPHENIDATE 30 MG/9 HR PATCH in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures METHYLPHENIDATE 30 MG/9 HR PATCH?
METHYLPHENIDATE 30 MG/9 HR PATCH (NDC 00378826393) is labeled by Mylan Pharmaceuticals Inc., and CMS classifies it as a generic product.